Τίτλος:
Interpreting the results of the VERTIS-CV trial: Is this the end of the “class effect” perspective? [解读VERTIS-CV试验的结果:这是“类效应”视角的终结吗?]
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Συγγραφείς:
Koufakis, T.
Papanas, N.
Dimitriadis, G.
Zebekakis, P.
Kotsa, K.
Περιοδικό:
WORLD JOURNAL OF DIABETES
Εκδότης:
John Wiley and Sons Inc
Λέξεις-κλειδιά:
ertugliflozin; hemoglobin A1c; ertugliflozin; fused heterocyclic rings; glycosylated hemoglobin, all cause mortality; body mass; drug efficacy; drug safety; drug screening; estimated glomerular filtration rate; hemoglobin blood level; hospital admission; hospitalization; human; incidence; non insulin dependent diabetes mellitus; Note; priority journal; randomized controlled trial (topic); treatment outcome; trend study; aged; blood; cardiovascular disease; clinical trial; controlled study; follow up; glucose blood level; metabolism; middle aged; non insulin dependent diabetes mellitus; phase 3 clinical trial; procedures; randomized controlled trial, Aged; Blood Glucose; Bridged Bicyclo Compounds, Heterocyclic; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Follow-Up Studies; Glycated Hemoglobin A; Humans; Middle Aged; Outcome Assessment, Health Care; Sodium-Glucose Transporter 2 Inhibitors
DOI:
10.1111/1753-0407.13105
